Takeda Pharmaceutical Company Limited Takeda (NYSE: TAK) Announces Submission Of NDA For Lanadelumab In Japan Takeda Pharmaceutical Company Limited (NYSE: TAK) declared Friday that it has submitted New Drug Application (NDA) for Lanadelumab to the Ministry of Health, Labour and Welfare (MHLW) in Japan.